Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Emergency Medical Technician Treat-and-leave Patients Receiving Telemedicine Consultation With Emergency Medical Dispatch Physician - a Controlled Before and After Pilot-study

8 de diciembre de 2015 actualizado por: University of Aarhus

A large part of acutely ill patient's access to the health care system starts by calling the emergency number 1-1-2 and thereby getting in touch with the emergency medical dispatch center (EMDC). In most cases an ambulance is dispatched and the patient is brought to the hospital. These patients are not referred by a physician (eg. a GP) and represent an unselected subpopulation of the acutely ill patients. At present, all non-critically ill patients not evaluated by a pre-hospital physician are normally be transported to hospital as category 2 (without activated emergency lightning and sirens).A part of this patient population, however, is not critically ill and a proportion of these may not need hospital admittance . Emergency medical technicians (EM) are not allowed to treat - and- leave patients without a physician's involvement. If the EMT had 24/7 online access to medical control i.e. in form of a physician present in the EMDC , the number of patients transported to hospital for assessment may be reduced as well as response times for patients actually needing ambulance transportation. This could potentially reduce the workload on the whole healthcare system involved in the management of these patients - thereby potentially reducing costs.

The objective of this study is to evaluate if a systematic telemedical assessment by an EMDC-physician of all patients who receive an ambulance but are not critically ill and would have a category 2 transport to hospital can reduce the number of the patients that are transported to hospital and save costs and time.

Descripción general del estudio

Estado

Terminado

Intervención / Tratamiento

Tipo de estudio

Intervencionista

Inscripción (Actual)

774

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Aarhus N, Dinamarca, 8200N
        • Prehospital Emergency Medical Services, Aarhus

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Patients receiving an emergency ambulance after calling the EMDC Patients who are going to be admitted to a Hospital in the Central Denmark Region.
  • Patients who are going to be transported as category 2 patients (non-critical illness, not requiring transport with activated lightning and sirens.

Exclusion Criteria:

  • Critically ill patients (Patients who are going to be transported as category 1 patients (critical-illness, requiring immediate transport with activated sirens and warning lights )
  • Patients who are not supposed to be admitted to a hospital in the Central Denmark Region

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Telemedicine consultation
EMTs will systematically establish teleconsultation by either telephone or video with the EMDC-physician in all cases of non-critical illness
Telemedicine consultation done by telephone or video
Otros nombres:
  • For video consultation iPAD AIR 4G/3G 16 GB will be used.
  • LifeSize ClearSea solution will be used for videoconferencing.
  • 4G/3G mobile network.
  • For telephone consultation Nokia C2-01 GSM telephone will be used.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Expenses related to EMDC physician vs. savings obtained by avoided admissions
Periodo de tiempo: Will be assessed at the time of consultation, expected to be presented within 36 months after assessment
Cost of 24 hour EMDC physician vs. savings obtained by avoided admissions. Calculations of average transport related costs will be provided by the Prehospital Emergency Medical Services Aarhus and average cost of hospitalization for a patient hospitalized 24 hours or less at the emergency dept. will be provided by the Regional Hospital Horsens. The percentage of treat-and-leave patients in the intervention period will be compared to a historical control group represented by the average percentage of treat-and-leave patients for the previous 12 months (August 2013 to August 2014). The savings obtained by avoided admissions will be calculated by multiplying the difference in the proportion of treat and leave patients with the number of patients the previous 12 months who are receiving an ambulance after dialing 112. The EMDC physician related costs will be calculated from the present table of salary for specialist physicians in Denmark.
Will be assessed at the time of consultation, expected to be presented within 36 months after assessment

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Percentage of avoided hospital admissions
Periodo de tiempo: Treated-and-left or not will be assessed at the time of consultation, expected to be presented within 36 months of assessment
Is the difference in percentage of treat-and-leave patients in the intervention period and historical control period
Treated-and-left or not will be assessed at the time of consultation, expected to be presented within 36 months of assessment
Response time for ambulances
Periodo de tiempo: Is assessed at the time the EMT registers arrival on site, expected to be presented within 36 months of assessment
Defined as the average response time for ambulances dispatched by EMDC. The average response time is calculated as the time where the emergency medical dispatcher gets an assignment (registered manually by the dispatcher) to the arrival of the ambulance at scene (registered manually by the EMS technician). This definition of response time is predefined politically and is the gold standard for this measurement across dispatch centers in Denmark.
Is assessed at the time the EMT registers arrival on site, expected to be presented within 36 months of assessment
Hospital admission within 3 days
Periodo de tiempo: Will be assessed at the 72 hours after consultation, expected to be presented within 36 months of assessment
Percentage of patients where initial hospital admission is avoided, but are admitted to hospital within 72 hours after primary contact.
Will be assessed at the 72 hours after consultation, expected to be presented within 36 months of assessment
Time consumption by EMDC physician
Periodo de tiempo: Will be assessed within 1 minute after end of consultation, expected to be presented within 36 months after assessment
Registered as the time from receiving phone call or establishing video contact to connection is discontinued
Will be assessed within 1 minute after end of consultation, expected to be presented within 36 months after assessment
Cause of death
Periodo de tiempo: Will be assessed as soon as possible after the occurence of death, normally within 24 hours, expected to be presented within 36 months of assessment
Audit on all patients dying within 30 days of primary contact. Patient's electronic medical record will be assessed by two independent consultant physicians with no relation to EMDC in order to evaluate if death of a treat-and-leave patient can be attributed to treat-and-leave
Will be assessed as soon as possible after the occurence of death, normally within 24 hours, expected to be presented within 36 months of assessment
Patient's evaluation
Periodo de tiempo: Will be assessed within 72 hours after end of consultation, expected to be presented within 36 months after assessment
Patient's evaluation of prehospital care. Telephone survey of all included patients in the intervention period will be conducted within 72 hours after teleconsultation with EMDC-physician
Will be assessed within 72 hours after end of consultation, expected to be presented within 36 months after assessment

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de septiembre de 2014

Finalización primaria (Actual)

1 de noviembre de 2014

Finalización del estudio (Actual)

1 de noviembre de 2014

Fechas de registro del estudio

Enviado por primera vez

11 de julio de 2014

Primero enviado que cumplió con los criterios de control de calidad

26 de agosto de 2014

Publicado por primera vez (Estimar)

29 de agosto de 2014

Actualizaciones de registros de estudio

Última actualización publicada (Estimar)

9 de diciembre de 2015

Última actualización enviada que cumplió con los criterios de control de calidad

8 de diciembre de 2015

Última verificación

1 de julio de 2014

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • NRA5

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir